Clinical significance of the m6A methyltransferase METTL3 in peripheral blood of patients with coronary heart disease
The increased expression of METTL3 in peripheral blood may serve as a potential biomarker and predictive factor for CHD.
Authors
- R. Shao (ORCID: https://orcid.org/0000-0001-5044-5954)
- Xiangshan Xu (ORCID: https://orcid.org/0000-0002-5301-4540)
- Yuanzhe Jin
- Jianshe Chang
Institutions
- Fourth Affiliated Hospital of China Medical University (CN)
- Dongfeng General Hospital (CN)
- China Medical University (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2024-09-20
- DOI
- https://doi.org/10.3389/fcvm.2024.1442098
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.23